Many factors must be considered and discussed with women when initiating a contraceptive
method and the risk of venous thromboembolism (VTE) is one of them. In this review, we …

Background Combined oral contraceptives (COC s) containing various progestogens could
be associated with differential risks for venous thromboembolism (VTE). Objective To …

Background Women with medical conditions associated with increased risk for thrombosis
generally should not use estrogen-containing contraceptives; however, less is known about …

Since the early 1960s, it has been well documented that combined hormonal contraceptives
increase the risk of cardiovascular disease. Newer generation of oral formulations, as well …

OBJECTIVE: To investigate associations between combined hormonal contraception and
progestogen-only contraception and risks of venous thromboembolism by progestogen and …

Introduction Contraceptives containing ethinylestradiol (EE) induce changes in the
coagulation system and are associated with a risk of venous thromboembolism. However …

The present invention relates to pharmaceutical compositions and kits comprising
pharmaceutical compositions, and methods for administering pharmaceutical compositions …

Introduction: The pharmacodynamic effects of various combined oral estrogen-progestin
combinations (COC) are examined for their components alone or in the various combined …

OBJECTIVE: To evaluate associations between use of seven progestogens and incident
acute venous thromboembolism (VTE) among women of reproductive age. METHODS: This …

Objective Since its introduction 50 years ago, the contraceptive pill has continuously evolved
to decrease the risk of venous thromboembolism (VTE) associated with its use. An increased …